(Q51296155)

2 April 2018

title

Salivary IgA in response to periodontal treatment. (English)

1 reference

2 April 2018

author name string

Stefan J Hägewald

1

1 reference

2 April 2018

Daniel L W Fishel

2

1 reference

2 April 2018

Claudia E B Christan

3

1 reference

2 April 2018

Jean-Pierre Bernimoulin

4

1 reference

2 April 2018

Andreas Kage

5

1 reference

2 April 2018

publication date

1 June 2003

1 reference

2 April 2018

European Journal of Oral Sciences

published in

1 reference

2 April 2018

volume

111

1 reference

2 April 2018

issue

3

1 reference

2 April 2018

page(s)

203-208

1 reference

2 April 2018

Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Oral mucosal immunity and HIV infection: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Physiology of IgA and IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

A component of innate immunity prevents bacterial biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

IgA production without mu or delta chain expression in developing B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Effect of periodontal treatment on the protein composition of whole and parotid saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

T cell control of the gut IgA response against commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

A revisit of mucosal IgA immunity and oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Induction of Oral Tolerance in the Primed Immune System: Influence of Antigen Persistence and Adjuvant Form

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Humoral immune responses in periodontal disease may have mucosal and systemic immune features

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

Development of a classification system for periodontal diseases and conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Early-onset periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Classification of periodontal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Predominant microflora of severe, moderate and minimal periodontal lesions in young adults with rapidly progressive periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Salivary IgA responses to bacteria in dental plaque as related to periodontal and HIV infection status

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Total IgA and Porphyromonas gingivalis-reactive IgA in the saliva of patients with generalised early-onset periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Differential effects of active versus passive coping on secretory immunity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Immunodominant antigens in periodontal disease: a real or illusive concept?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Protein composition of whole and parotid saliva in healthy and periodontitis subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Parotid salivary S-IgA antibodies during experimental gingivitis in smokers and non-smokers.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Association of salivary immunoglobulin A antibody and initial mutans streptococcal infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Salivary IgA responses to Porphyromonas gingivalis in the cynomolgus monkey. I. Total IgA and IgA antibody levels to P. gingivalis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Antibody responses against Porphyromonas gingivalis infection in patients with early-onset periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Humoral immunity in root caries in an elderly population. 1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0722.2003.00040.X

7 January 2021

10.1034/J.1600-0722.2003.00040.X

Identifiers

DOI

1 reference

2 April 2018

PubMed ID

12786950

1 reference

2 April 2018